Skip to main content

Insulin NPH

01-04-2021 | Insulin | News

Long-acting insulin analogs may lower hypoglycemia risk in older people with type 2 diabetes

Older people with type 2 diabetes who initiate treatment with long-acting insulin analogs have a lower risk for severe hypoglycemia than those using neutral protamine Hagedorn insulin, real-world study findings suggest.

09-07-2018 | Insulin | News

Few efficacy and safety differences between long-acting insulins

The results of a network meta-analysis suggest that long-acting insulin analogs have broadly equivalent efficacy and safety in patients with type 2 diabetes, although some might be a little better for preventing nocturnal hypoglycemia.